Tempest Therapeutics Stock (NASDAQ:TPST), Quotes and News Summary

Q: What sector and industry does Tempest Therapeutics (TPST) operate in?

Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Tempest Therapeutics Stock (NASDAQ: TPST) stock price, news, charts, stock research, profile.

Open	$3.370
Close	-
Volume / Avg.	115.012K / 979.764K
Day Range	3.310 - 3.430
52 Wk Range	0.170 - 9.770
Market Cap	$75.761M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	5.48%
Days to Cover	1.53

Recent News

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Avi Kapoor

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

Lisa Levin

Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53. The S&P 500 also rose, gaining, 0.16% to 4,389.61.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Tempest Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tempest Therapeutics (TPST) stock?

You can purchase shares of Tempest Therapeutics (NASDAQ: TPST) through any online brokerage.

View our list of the best stock brokerages.

Who are Tempest Therapeutics's (TPST) competitors?

Other companies in Tempest Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Gritstone Bio (NASDAQ:GRTS).

What is the target price for Tempest Therapeutics (TPST) stock?

The latest price target for Tempest Therapeutics (NASDAQ: TPST) was reported by HC Wainwright & Co. on Wednesday, March 20, 2024. The analyst firm set a price target for 47.00 expecting TPST to rise to within 12 months (a possible 1299.52% upside). 11 analyst firms have reported ratings in the last year.

Current Stock Price for Tempest Therapeutics (TPST)?

The stock price for Tempest Therapeutics (NASDAQ: TPST) is $3.3583 last updated Today at April 25, 2024 at 12:33 PM EDT.

Does Tempest Therapeutics (TPST) pay a dividend?

There are no upcoming dividends for Tempest Therapeutics.

When is Tempest Therapeutics (NASDAQ:TPST) reporting earnings?

Tempest Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Tempest Therapeutics (TPST) going to split?

There is no upcoming split for Tempest Therapeutics.

What sector and industry does Tempest Therapeutics (TPST) operate in?

Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-